Form D · Biotechnology
EnGraft Technologies, Inc.
Marina Del Rey, CA · CIK 0001976533
Offering snapshot reported Jun 6, 2023 · SEC filing
- Reported sold
- $1M Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- May 24, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 6, 2023 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-483390
Source: Form D, filed Jun 6, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Richard Rassman | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4337 Marina City Drive Unit 527
Marina Del Rey, CA, 90292
Marina Del Rey, CA, 90292